Details of the Drug

General Information of Drug (ID: DMXV116)

Drug Name

PF-05180999

Indication

Disease Entry	ICD 11	Status	REF
Schizophrenia	6A20	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C19H17F3N8
Canonical SMILES: CC1=NC(=C2N1N=CN=C2N3CCC3)C4=C(N(N=C4)C)C5=NC=C(C=C5)C(F)(F)F
InChI: 1S/C19H17F3N8/c1-11-27-15(17-18(29-6-3-7-29)24-10-26-30(11)17)13-9-25-28(2)16(13)14-5-4-12(8-23-14)19(20,21)22/h4-5,8-10H,3,6-7H2,1-2H3
InChIKey: CLGCHUKGBICQTE-UHFFFAOYSA-N

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01530529) A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999. U.S. National Institutes of Health.